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Purified cdc2 or ¢xlc2 obtained from HeLa cells in association with p13 '~t activate inactive type.l protein phosphatas¢ (PPI) (catalytic subanit 
• inhibitor-2 complex, purified from skeletal muscle). Likewise in the ease of PPI activation by FA/GSK3, activation by ed¢2 is accompanied by
phosphorylation f inhibitor-2 (12) and free I2 can be phosphorylated as well. Correlation between PP1 activation and I2 phosphorylation s 
suggested by the fact that both activation and phosphorylation (a) increase inparallel during incubation with ode2, (b) decrease in parallel upon 
subsequent e.dc2 inhibition by EDTA, and (c) are inhibited by the cole2 inhibitor 5,6-dichloreben~midazole rib side, cdc2 also phosphorylates he
catalytic subunit of PPI, wh~ther in the complex with 12 or as free molecule. The activation of PPI by eric2 and by FA/GSK3 is compared. 
Protein phosphatase; Protein kinase; Phosphorylation; Cell cycle 
1, INTRODUCTION 
Protein phosphatase oftype- 1 (PP1) is the most abun- 
dant serine/threonine phosphatase in most cells (see [1] 
for review) and is regulated by hormones and growth 
factors [2-5] and during the cell cycle [6-8]. The PPI 
catalytic subunit exists in various active (E,) and inac- 
tive (E) conformations [9] and is purified either as a free 
catalytic subunit or bound to the regulatory subunits 
inhibitor 2 (I2) and G [1010,11]. Regulation of PP1 is 
primarily through phosphorylation of its regulatory 
subunits. In fact the kinase FA/GSK3 and casein kinase 
II activate the cytosolic PP1 by phosphorylating the 
regulatory subunit I2 [9,12,13]; an insulin-stimulated 
kinase ([14] identical to the 90K $6 kinase) activates PP1 
by phosphorylating the G-subunit in muscle glycogen 
particles, and also protein kinase A inhibits PPI 
through the G-subunit (reviewed in [1]). Additionally, 
PP1 may be regulated by tyrosine phosphorylation of 
the catalytic subunit by the kinases v-sr¢ or e-src [15,16] 
and v-abl [17]. Tyrosine phosphorylation occurs in the 
Abbreviations: TPCK, N.tosyI.L-phenylalanine chloromethyl ketone; 
PMSF, phenylmethylsulfonyl fluoride; 2-ME, 2-mercaptoethanol; 
D'VI', dithiothreitol; DRB, 5,6-dichlorobenzimidazole riboside; 
HEPI/S, N-[2-hydroxyethyl]piperazine-N'-[ethanesaifonic acid]; BSA,
boviAi¢ serum albumin; SDS, sodium dod.r.cyl sulfate; DMEM,  Dul- 
be~o's Modifi~ Eagle Medium; PPI, protein phosphatase of type.l; 
E., active catalytic subunit of PPI; E+, inactive catalytic subunit of PPl; 
E~ • I2, inactive cytosolic PPI complex; I2, inhibitor-2 of PFI; FA/ 
GSK3, protein kinase that activates PPi, also called glycogen synthase 
kinase-3; ~¢2, cyclin-depcndent serine kinase that is activated at the 
G2/M transition of cell cycle. 
Correspondence address: E. Villa-Mortazzi° Dipartimento di Bio- 
medicine, Sezione di Patologia Generale, via Rome 55, 56126 Pisa, 
Italy. Fax: (39) (50) 554929. 
C-terminal, trypsin-sensitive r gion of  the catalytic sub- 
unit and may inhibit the activity [15,16] or facilitate the 
inactivation by 12 in diluted conditions [17]. 
edc2 is the catalytic subunit of the kinase complex 
that is activated at both the mitotic and meiotic M phase 
in eukaryotic ells. The activation of edc2 at the M 
phase is controlled by reversible multiple phosphoryla- 
lions and association with cyclins (see [18-20] for re- 
view). Dephosphorylation f cdc2 is thought o be the 
final event to activate the kinase and involves the tyro- 
sine phosphatase ode25 [21] as well as okadaie acid- 
sensitive serine/threonine phosphatases, uch as PPI 
and protein phosphatase-2A [8]. A number of substrates 
are supposedly phosphorylated by the activated ode2 
and these, in turn, may lead to the major M-phase 
events uch as chromosome condensation, uclear enve- 
lope breakdown and cytoskeletal reorganization. Al- 
though few such substrates have been found so far (re- 
viewed in [22]), their identification and the assessment 
of their role 'in rico' is of  primary importance for the 
understanding of the M-phase events. Here we report 
that PPI might be one of such substrates ince ode2 
purified from HeLa cells phosphorylates and activates 
PPI. 
2. MATERIALS AND METHODS 
2.1. Materials 
ATP, BSAo PMSF. benzamidine, DTr, TPCK, DRB, HEPES and 
molecular weight markers were purchased from Sigma. [3'PlPi was 
from DuPont. Hy~rtilms-MP were from Amersharn. The chemicals 
for electrophoresis were from Bio-Rad. Triton X-100 and leupeptin 
were from Boehringer. Protein A-Sepharose was from Pierce. The 
Opti Phase I1 seintillant was from LKB. 
2.2. Cell euhure and extracts 
HeLa cells were grown on 150-ram tissue culture plates in DMEM 
Published by EIA'evier Science Publishers B. V. 211 
Volume 304, number 2,3 FEBS LETTERS June 1992 
supplemented with 1 mM sodium pyruvate, 1 mM non-essential mino 
acids, 10% foetal calf serum, 100 units/ml p~nicillin and 100/~g,/ml 
streptomycin at 370C with 5% CO,, After washing twice wit h 5 ml cold 
PBS. the cells were scraped offwith a rubber policeman i  the presence 
of 10 mM HEPES, pH 7.4, 0,1 mM EDTA, 10 mM NaCI, 0,004% 
benzamidine. 0.004% PMSF, 0,004% TPCK, 4/.tg/ml cupeptin, 30 
mM 2-ME, broken with 20 strokes in a Doune~ homogenizer at4°C 
and centrifuged at 23,000 x g for 90 rain. The supernatant thus ob- 
tained, defined as cytosolic fraction, was quickly frozen and stored at 
-70°C for subsequent assay, 
2,3. En'.yme and protein purifications 
Inactive cytosolic PPI E~. I2 complex [23l, cytosolic free E,, [24], I2 
[12] and phosphorylase b were purified from rabbit skeletal muscle 
[9.23]. cdc2 purified from HeLa cells [25], p13 `~ covalently bound to 
Sepharose (pl3-beads, [26 l) and anti.human cde2 peptide antiserum 
(36 [27] were a gift from Dr, G, Draetta (EMBL, Heidelberg, Ger- 
many), F^/GSK3 was purified from rabbit skeletal muscle up to the 
Blue Sepharose chromatography [28], Muscle phosphorylase kinase 
was a gift from Dr, L,M,G. Heilme~,er (Ruhruniversit'at-Boeb.um, 
(3ermany), Rabbit muscle phospho~lase b was used to produce 3:p. 
labeled phosphor~'lase a [29], [~:P]ATP (2000 Ci/mmol) was prepared 
using inorganic ['~-'P]phosphate ( s described in [29]), Protein was de- 
termined by the method of Bradford [30], using BSA as a standard, 
2,4, pl3"a.bead precipitate~" and hnm~¢noprecipltates 
40/al pl3-beads [26] rcsuspended in 1 vol. of PBS was used to bind 
cdc2 from HeLa c¢11 cytosolic fractions during 30 rain rotation at 4°C. 
Alternatively edc2 was immunoprecipitated from 1.8 ms of HeLa c¢11 
cytosolie fractions with 5/.tl of anti-human cdc2 peptide an tiserum G6 
[27] during 4 h incubation at 4°C, followed by the addition of 40/~1 
Protein A-Scpharos¢ resuspended in 1 vol, PBS and 30 rain rotation 
at 4"C, The pellets were washed three times in 50 mM Tris, pH 7,5, 
5 mM EDTA, 0,4 M NaCl, 0.1% Triton X-100, 0,002% benzamidine, 
0,002% PMSF and 15 mM 2-ME, and used as source of active cd¢2 
kinase, 
2,5. PPI acth'atlon and assays 
Inactive PPI E~. I2 complex (0,1-0.2 pg) was activated by cdc2 or 
F^/(3SK3 [32] during incubation for 2 min, unless otherwise stated, 
at 300C in the presence of 0.5 mM ATP (Fig, 1) or 0,05 mM ATP 
(Figs. 3 and 4) and 1 mM Mg 2". in 25bd PPl assay buffer [9], PPI was 
assayed by the release of ~:PL from ['~:P]phosphnrylase  (1-2 x lO s 
cpm/nmol) in 50 /al final volume [9.23] and the ~"P~ released was 
counted in aft scintillation counter using the Opti Phase II seintillam, 
2,6, Phosphorylation el i2 and PPI 
For the phosphorylation f free I2 and PPl shown in Fig, 2, 25 mM 
Tris, pH 7,5, 80/tM ATP, 6 mM MS"'. 0,8 mM DTT, 30 mM NaY, 
5-10 x 10 z cpm/pmol [~"P]ATP, 12, PP1 and protein kinases as specifi- 
caliy indicated were incubated in 20-25/al at 30°C, For the PPl 
phosphorylation shown in Figs. 3 and 4, 25 mM imidazole, pH 7,5, 
50/tM ATP, I mM Mg ~÷, 15 mM 2-ME, 80-120 x 10 ~ cpm/pmol 
[~:P]ATP, PPI and protein kinases as specifically indicated were incu- 
bated in 125/~1 at 30°C, At the indicated time-points 25/zl aliquots 
were mixed with I vol, of Laemmli buffer, boiled for 3 rain and 
subjected to 10% SDS-PAGE [31] and autoradiography b  exposure 
to Hyperfilm-MP at -70°C with intensifying screen, To measure the 
phosphorylation f I2 or of the PPl catalytic subunit (38 kDa protein) 
the corresponding protein bands were excised from the ~el, hydrated, 
mixed with Opti Phase 1I scintillant and counted in ap scintillation 
counter. The stoichiometry of the phospho~lation was calculated 
ansuming phosphorylation one site and the molecular weight used 
for I2 was 22,835, as deduced by protein sequence [I], 
3. RESULTS AND DISCUSSION 
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Fig, 1. (A) Activation of the inactive PPI E~. I2 complex by cdc2 or 
by two different FA/GSK3 preparations (FAI and F^2), 200 ng of 
inactive PPl was incubated with 100 ng purified edc2 or 67 ng FAI or 
86 ng FA2, for 2 mln at 30°C in the presence of 0.5 mM ATP and 1 
mM Mg '÷, followed by 3-rain phosphatase assay, as described in 
section 2. IneubatiOlaS containing PPI or kinas¢ only were run in 
parallel. (B) 1/ag of PPl was incubated with 25 ng cdc2 as in (A), in 
a final volume of 125/tl, At each time point a 25 pl aliquot was taken 
for a 3-min PPI assay (e). The PPI activity generated by the activation 
was calculated after subtracting the cpm of parallel incubations that 
contained PPI or kinase only, PPI activity is given as pmol of P~ 
liberated from the substrate phosphorylase a per min during the 3-min 
PPI assay. (C) The indicated amounts of edc2 (e) or FA2 (&) were 
incubated with 200 ng PPI for 2 mix, under the conditions indicated 
in (A), followed by a 3-min phosphatase assay, PPl activity was 
calculated as in (B), 
associat ion with p l3 -beads  was found to activate ex- 
ogenous inactive PP1 (E i '  I2 complex).  Since such cdc2 
preparat ion still conta ins  contaminants  that might  be 
responsible for the act ivat ion,  the exper iments were re- 
peated with cdc2 purif ied f rom HeLa  cells [25] (in this 
preparat ion  cde2 and cyclins accounted  for  over 90% o f  
the protein detected on si lver-stained SDS gel electro- 
phoresis). In Fig. IA  the act ivat ion o f  PP l  by purif ied 
cdc2 is shown and compared  with the act ivat ion by two 
preparat ions  o f  FA/GSK3.  Act ivat ion by cdc2 was lin- 
ear in t ime for the first few minutes (Fig. 1B) (similar 
to what  was described in the case o f  FA/GSK3 [9,32]) 
and with respect to the amount  o f  protein used, within 
the protein concentrat ions  tested (Fig. 1C). Fig. [C also 
shows the l inearity o f  PP1 act ivat ion by FA2. F rom the 
data  o f  Fig. 1 B and C the specific activity o f  cdc2 as PP 1 
act ivator  was found to be 170 U /mg at 2 mix incubat ion 
(calculated after subtract ing the cpm due to PP I  or  
kinase a lone f rom the cpm obta ined in the presence o f  
both PP1 and  kinase), while FA2 had specific activity o f  
340 U/mg.  PP1 act ivat ion by ode2 was lost in the pres- 
ence o f  the edc2 inhibitor 5,6-d ichlorobenzimidazole ri- 
beside (DRB)  (not  shown).  
. . . . .  h,d ..... that shares The results descr ibed -1" . . .  "" ;"-"~ cd¢2 
with FA/GSK3 the ability to act ivate PP I .  PP1 activa- 
t ion by FA/GSK3 involves phosphory la t ion  o f  I2 in the 
PP l  complex  [9,10012,13] and convers ion of  the cata-  
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Fig. 2. (A) Phosphorylation of 12 (1/~) by immunoprecipitated cdc2. For each incubation erie2 ~vas precipitated from 1.8 mg of HeLa cell cytosolic 
fraction with anti.human cd¢2 pgptid= antiserum (ab), in the absence or in the presence ofthe peptide (pep) used as irnmunogen, and incubated 
in the presence of[~2P]ATP for 30 rain at 30°C with or without I2.12 phosphorylated by 50 ng protein kinase A (PKA) was used as 12 marker. 
(B) Phosphorylation f I2 (2 #g) by purified cd¢2 (20 rig) or Fa/GSK3 (14 ng). 12 was incubated inthe presence of[~=P]ATP for 60 rain at 30"13 
with or without kinase. One incubation contained also 500 ~M ofth¢ cd¢2 kinase inhibitor DRB. (C) Phosphorylation of PPI (38 k Ei • 12 complex) 
by exlc2 or FA/GSK3. 1/tg ofPPl ~vas incubated with 50 ng oi'cd¢2 or 68 ng of FA/GSK3 for 30 rain at 30"12, in the presence of[~2P]ATP. Standard 
proteins: 116 k, ~-galaetosidase; 68 k, BSA; 43 k, ovalbumin; 29 k, carbonic anhydrase. Incubation conditions are further described in section 2. 
lytic subunit from inactive (E) to active form (EL) [9]. 
During activation 12 phosphorylation i the PP1 com- 
plex by FA/GSK3 is just measurable [13], and this may 
be explained by dephosphorylation f I2 by the acti- 
vated complex [23]. However, also phosphorylation of 
free I2 by FA/GSK3 is very low (up to 0.3 mol/mol in 
[13]). In order to test whether also PPI activation by 
cdc2 involved I2 phospho~lation it was first tested 
whether I2 was a substrate for cdc2. cdc2 immunopre- 
cipitated from HeLa cell extracts with anti-cdc2 anti- 
bodies phosphorylated free 12. Phosphorylation did not 
occur in a control immunoprecipitate in which the pep- 
tide used as immunogen was added to prevent forma- 
tion of the cdc2-antibody complex (Fig. 2A). Purified 
cdc2 phosphorylated free I2 at higher degree. Phospho- 
rylation by cdc2 was also higher than phosphorylation 
by a comparable amount of FA/GSK3 (Fig. 2B) and did 
not occur in the presence of the cdc2 kinase inhibitor 
DRB (Fig. 2B). cxlc2 phosphorylated I2 also in the PPI 
E~ • 12 complex (Fig. 2C) and phosphorylation was in- 
hibited by DRB (not shown). Surprisingly cdc2 
phosphorylated also the 38 kDa catalytic subunit of 
PPI (Fig. 2C). In a separate xperiment i was found 
that cdc2 phosphorylated also the free active EL form 
(purified from muscle cytosol) without affecting its ac- 
tivity and phosphorylation was in the: trypsin-sensitive 
C-terminal region, since the proteolyz,:d active form of 
E, was no longer phosphorylated (not shown). On the 
other hand FA/GSK3 phosphorylated 12only (Fig, 2C; 
see also below and Fig. 4A). 
The correlations between PPI ~'" .... " a,., . . . . Ion and phos- 
phorylation by ode2 and FA/GSK3 were investigated in
two parallel incubations, one to assay PPI activity and 
the other to measure 12 phosphorylation i  the presence 
of [~-'PIATP. The stoichiometry of 12 phosphorylation 
was calculated assuming phosphorylation on one site. 
Fig. 3 shows that the activation of PP1 by cdc2 was 
accompanied by parallel increase in I2 phosphorylation 
and both events were faster in the first few minutes of 
reaction but continued to increase throughout the incu- 
bation time. A comparable amount of FA/GSK3 in- 
duced higher PPI activation but lower I2 phosphoryla- 
tion (Fig. 3; compare also with ref. [13]). The two 
kinases together had additive effects on PPI activation 
and I2 phosphorylation, at least in the first few minutes 
of reaction. The differences between cdc2 and Fa/GSK3 
were confirmed upon prolonged incubation (Fig. 4A). 
Both PPI activation and I2 phosphorylation by edc2 
increased in parallel for up to 2 h and PP1 activation 
reached values comparable to that obtained with FA/ 
GSK3. On the other hand activation by FA/GSK3 
reached its maximum by 20 rain, during which time 12 
phosphorylation was constantly low (this is in agree- 
ment with previous data; see [9,13] for the FA/GSK3 
mechanism). In all these experiments inactive PP1 was 
present in excess and the activity generated by ode2 in 
2 h represented approximately 1% of the potential PPI 
activity in each assay, based on the activity that would 
be assayed after activation by trypsin and Mn 2÷ [9,23]. 
Fig. 4A shows also that the PPl catalytic subunit (38 
kDa protein) is phosphorylated by cdc2 (but not by 
FA/t3SK3) in a reaction that is almost linear with time 
for up to 2 h. 
Further indication of the involvement of I2 phospho- 
rylation in PP1 activation by edc2 came from studying 
the reversibility of the activation. In the experiment 
shown in Fig. 4B PPI was activated by cde2 for 10 min, 
then the kinase was inhibited by EDTA and the incuba- 
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Fig. 3. For activity assays 0.6/~g ofinactive PPI (E~, 12 complex) was 
incubated at 30'C with 30 ng ode2 or with 41 ng FA/OSK3 or with 
the same amounts of both kinases in 150/~120 mM imidazole, pH 7.5, 
0.05 mM ATP and 1 mM Mg '+. At each time point 25/~1 were taken 
to assay PPl activity. For I2 phosphorylation the incubation was as 
above bat contained in addition [s:P]ATP. At each time point 25/.tl 
were taken from for subsequent electrophoresis and autoradiography. 
The phosphory la t~ l  protein bands corresponding to 12 were excised 
from the ~el for radioactivity count and calculations of tool/tool phos- 
phorylation, as described in section 2, 
tion proceeded for the subsequent 110 , in .  Following 
kinase inhibition, PPI activation and 12 phosphoryla- 
tics returned almost to the basal values within 10-20 
min. Also PP1 activation by FA/GSK3 was reversed by 
EDTA with a similar time pattern (Fig. 3B and [9]), but 
in this case I2 dephosphorylation and PP1 inactivation 
were complete. 
Altogether the data shown in Figs. 3 and 4 suggest he 
involvement of I2 phosphorylation in PP1 activation by 
cde2. Furthermore, in 12 the P-Y-H sequence immedi- 
ately downstream the Thr-72 phosphorylated by FA/ 
GSK3 during PPI activation bears some resemblance to 
the S(T)-P-X-Z sequence recognized by cdc2 (where X 
is a polar amino acid and Z is generally a basic amino 
acid [22]), suggesting the possibility that also PPi acti- 
vation by cdc2 involves phosphorylation of Thr-72. On 
the other hand the present experiments indicate also 
differences in PP1 activation and 12 phosphorylation by 
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Fig, 4, (A) Incubations for PPI activation and phosphorylation were 
as in Fig, 3, In this experiment he tool/tool phosphorylation was 
calculated for both PPI catalytic subunit (38 kDa protein) and I2, in 
the way described in Fig, 3 and in section 2, (B) Incubation conditions 
were as in (A), After taking the 10 . in  aliquot, EDTA was added to 
10 mM final concentration, 
the two kinases. Consequently for a better understand- 
ing of the mechanism by which ode2 activates PP1 the 
I2 site(s) phosphorylated by cdc2 need to be investi- 
gated. For what concerns phosphorylation of the 38 
kDa catalytic subunit, it is less likely that this is respon- 
sible by itself for PP1 activation since (i) it occurs only 
when PP1 is activated by ode2 and not by FA/GSK3, (ii) 
it is less correlated in time with enzyme activation, (iii) 
it takes place also in the case of E,, a 38 kDa form that 
is already active, and removal of the phosphorylation 
site by proteolysis does not affect activity. However, 
such phosphorylation might have additional roles in 
PP1 regulation that need to be studied. Of equal impor- 
tance will be to assess if PP1 activation and phosphoryl- 
ation by ode2 may take place also 'in vivo'. 
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